Pharmaceutical stocks include large-cap drug makers and specialty pharma companies. AI analysis focuses on pipeline value, patent expiration risks, pricing power, and international revenue diversification from SEC filings.
Best Pharmaceutical Stocks to Buy in 2026
Top-rated pharmaceutical stocks ranked by AI confidence score. Dual AI analysis (Claude + ChatGPT) based on SEC 10-K and 10-Q filings. Last Updated: May 2026
CRMD
Confidence
90%
INVA
Confidence
88%
LLY
Confidence
86%
CPRX
Confidence
86%
ELTP
Confidence
84%
UTHR
Confidence
82%
VRTX
Confidence
81%
REGN
Confidence
80%
COLL
Confidence
80%
HRMY
Confidence
79%
BMRN
Confidence
76%
CELG-RI
Confidence
76%
All Pharmaceutical Stocks (449)
| Ticker | Company | AI Rating | Confidence | Action |
|---|---|---|---|---|
| SKVI | SKINVISIBLE, INC. | STRONG SELL | 98% | View Analysis → |
| WGRX | Wellgistics Health, Inc. | STRONG SELL | 97% | View Analysis → |
| SKYE | Skye Bioscience, Inc. | STRONG SELL | 97% | View Analysis → |
| PRPH | ProPhase Labs, Inc. | STRONG SELL | 97% | View Analysis → |
| SVRA | Savara Inc | STRONG SELL | 96% | View Analysis → |
| KAYS | Kaya Holdings, Inc. | STRONG SELL | 96% | View Analysis → |
| RGPX | REGENEREX PHARMA, INC. | STRONG SELL | 96% | View Analysis → |
| GCAN | Greater Cannabis Company, Inc. | STRONG SELL | 96% | View Analysis → |
| EMMA | Emmaus Life Sciences, Inc. | STRONG SELL | 96% | View Analysis → |
| CPMD | CANNAPHARMARX, INC. | STRONG SELL | 96% | View Analysis → |
| CPHI | CHINA PHARMA HOLDINGS, INC. | STRONG SELL | 96% | View Analysis → |
| CLSDQ | Clearside Biomedical, Inc. | STRONG SELL | 96% | View Analysis → |
| CLCS | Cell Source, Inc. | STRONG SELL | 96% | View Analysis → |
| CELUW | Celularity Inc | STRONG SELL | 96% | View Analysis → |
| ZVSA | ZyVersa Therapeutics, Inc. | STRONG SELL | 95% | View Analysis → |
| ZSTK | ZeroStack Corp. | STRONG SELL | 95% | View Analysis → |
| WHWK | Whitehawk Therapeutics, Inc. | STRONG SELL | 95% | View Analysis → |
| VNDA | Vanda Pharmaceuticals Inc. | STRONG SELL | 95% | View Analysis → |
| VICP | Vicapsys Life Sciences, Inc. | STRONG SELL | 95% | View Analysis → |
| VCNX | VACCINEX, INC. | STRONG SELL | 95% | View Analysis → |
| UNCY | Unicycive Therapeutics, Inc. | STRONG SELL | 95% | View Analysis → |
| TCRT | Alaunos Therapeutics, Inc. | STRONG SELL | 95% | View Analysis → |
| STEK | Stemtech Corp | STRONG SELL | 95% | View Analysis → |
| SMNRW | Semnur Pharmaceuticals, Inc. | STRONG SELL | 95% | View Analysis → |
| SLNCF | Silence Therapeutics plc | STRONG SELL | 95% | View Analysis → |
| SILO | Silo Pharma, Inc. | STRONG SELL | 95% | View Analysis → |
| RTEZ | REST EZ Inc. | STRONG SELL | 95% | View Analysis → |
| OTLC | Oncotelic Therapeutics, Inc. | STRONG SELL | 95% | View Analysis → |
| PVCT | PROVECTUS BIOPHARMACEUTICALS, INC. | STRONG SELL | 95% | View Analysis → |
| PTN | PALATIN TECHNOLOGIES INC | STRONG SELL | 95% | View Analysis → |
| PPCB | Propanc Biopharma, Inc. | STRONG SELL | 95% | View Analysis → |
| PMN | ProMIS Neurosciences Inc. | STRONG SELL | 95% | View Analysis → |
| PKTX | ProtoKinetix, Inc. | STRONG SELL | 95% | View Analysis → |
| NIKA | NIKA PHARMACEUTICALS, INC | STRONG SELL | 95% | View Analysis → |
| MDCXW | Medicus Pharma Ltd. | STRONG SELL | 95% | View Analysis → |
| MCUJF | MEDICURE INC | STRONG SELL | 95% | View Analysis → |
| NASC | Can B Corp | STRONG SELL | 94% | View Analysis → |
| MAIA | MAIA Biotechnology, Inc. | STRONG SELL | 94% | View Analysis → |
| JAGX | Jaguar Health, Inc. | STRONG SELL | 94% | View Analysis → |
| ITRM | Iterum Therapeutics plc | STRONG SELL | 94% | View Analysis → |
| GELS | Gelteq Ltd | SELL | 94% | View Analysis → |
| GALT | GALECTIN THERAPEUTICS INC | STRONG SELL | 94% | View Analysis → |
| ERNAW | Ernexa Therapeutics Inc. | STRONG SELL | 94% | View Analysis → |
| ENVB | Enveric Biosciences, Inc. | STRONG SELL | 94% | View Analysis → |
| ENSCW | Ensysce Biosciences, Inc. | STRONG SELL | 94% | View Analysis → |
| CYTOF | Altamira Therapeutics Ltd. | SELL | 94% | View Analysis → |
| CYDY | CytoDyn Inc. | STRONG SELL | 94% | View Analysis → |
| CTRVP | Hepion Pharmaceuticals, Inc. | STRONG SELL | 94% | View Analysis → |
| CNBX | CNBX Pharmaceuticals Inc. | STRONG SELL | 94% | View Analysis → |
| CLNN | Clene Inc. | STRONG SELL | 94% | View Analysis → |
| CASIF | CASI Pharmaceuticals, Inc. | STRONG SELL | 94% | View Analysis → |
| CANN | TREES Corp (Colorado) | STRONG SELL | 94% | View Analysis → |
| CALC | CalciMedica, Inc. | STRONG SELL | 94% | View Analysis → |
| SHPH | Shuttle Pharmaceuticals Holdings, Inc. | STRONG SELL | 93% | View Analysis → |
| HCWB | HCW Biologics Inc. | STRONG SELL | 93% | View Analysis → |
| IOBT | IO Biotech, Inc. | STRONG SELL | 93% | View Analysis → |
| INTI | Inhibitor Therapeutics, Inc. | STRONG SELL | 93% | View Analysis → |
| INO | INOVIO PHARMACEUTICALS, INC. | STRONG SELL | 93% | View Analysis → |
| EVFM | Evofem Biosciences, Inc. | STRONG SELL | 93% | View Analysis → |
| XENE | Xenon Pharmaceuticals Inc. | STRONG SELL | 92% | View Analysis → |
| XCUR | EXICURE, INC. | STRONG SELL | 92% | View Analysis → |
| VYNE | VYNE Therapeutics Inc. | STRONG SELL | 92% | View Analysis → |
| TVRD | Tvardi Therapeutics, Inc. | STRONG SELL | 92% | View Analysis → |
| TLPH | TALPHERA, INC. | STRONG SELL | 92% | View Analysis → |
| PMHS | Polomar Health Services, Inc. | STRONG SELL | 92% | View Analysis → |
| PGEN | PRECIGEN, INC. | STRONG SELL | 92% | View Analysis → |
| ORGS | Orgenesis Inc. | STRONG SELL | 92% | View Analysis → |
| NWBO | NORTHWEST BIOTHERAPEUTICS INC | STRONG SELL | 92% | View Analysis → |
| IBO | IMPACT BIOMEDICAL INC. | STRONG SELL | 92% | View Analysis → |
| NTHI | NEONC TECHNOLOGIES HOLDINGS, INC. | STRONG SELL | 92% | View Analysis → |
| MBRX | Moleculin Biotech, Inc. | STRONG SELL | 92% | View Analysis → |
| MANE | Veradermics, Inc | STRONG SELL | 92% | View Analysis → |
| LYEL | Lyell Immunopharma, Inc. | STRONG SELL | 92% | View Analysis → |
| ELTX | Elicio Therapeutics, Inc. | STRONG SELL | 92% | View Analysis → |
| DWTX | Dogwood Therapeutics, Inc. | STRONG SELL | 92% | View Analysis → |
| CVKD | Cadrenal Therapeutics, Inc. | STRONG SELL | 92% | View Analysis → |
| CMND | Clearmind Medicine Inc. | SELL | 92% | View Analysis → |
| CINGW | Cingulate Inc. | STRONG SELL | 92% | View Analysis → |
| BYSI | BeyondSpring Inc. | STRONG SELL | 92% | View Analysis → |
| NBY | NovaBay Pharmaceuticals, Inc. | STRONG SELL | 91% | View Analysis → |
| HLYK | HealthLynked Corp | STRONG SELL | 91% | View Analysis → |
| INDP | Indaptus Therapeutics, Inc. | STRONG SELL | 91% | View Analysis → |
| EVMN | Evommune, Inc. | STRONG SELL | 91% | View Analysis → |
| CTOR | CITIUS ONCOLOGY, INC. | STRONG SELL | 91% | View Analysis → |
| COSM | Cosmos Health Inc. | STRONG SELL | 91% | View Analysis → |
| COCP | Cocrystal Pharma, Inc. | STRONG SELL | 91% | View Analysis → |
| CNSP | CNS Pharmaceuticals, Inc. | STRONG SELL | 91% | View Analysis → |
| QURE | uniQure N.V. | STRONG SELL | 90% | View Analysis → |
| BMEA | Biomea Fusion, Inc. | STRONG SELL | 90% | View Analysis → |
| VGLS | VG Life Sciences Inc. | STRONG SELL | 90% | View Analysis → |
| SNGX | SOLIGENIX, INC. | STRONG SELL | 90% | View Analysis → |
| RVPH | REVIVA PHARMACEUTICALS HOLDINGS, INC. | STRONG SELL | 90% | View Analysis → |
| OSTX | OS Therapies Inc | STRONG SELL | 90% | View Analysis → |
| ONCO | Onconetix, Inc. | STRONG SELL | 90% | View Analysis → |
| LGVN | Longeveron Inc. | STRONG SELL | 90% | View Analysis → |
| KPTI | Karyopharm Therapeutics Inc. | STRONG SELL | 90% | View Analysis → |
| HURA | TuHURA Biosciences, Inc./NV | STRONG SELL | 90% | View Analysis → |
| GOSS | Gossamer Bio, Inc. | STRONG SELL | 90% | View Analysis → |
| RNTX | Rein Therapeutics, Inc. | STRONG SELL | 90% | View Analysis → |
| RGBPP | Regen BioPharma Inc | STRONG SELL | 90% | View Analysis → |
| FHTX | Foghorn Therapeutics Inc. | STRONG SELL | 90% | View Analysis → |
| FBLG | FibroBiologics, Inc. | STRONG SELL | 90% | View Analysis → |
| ELAB | PMGC Holdings Inc. | STRONG SELL | 90% | View Analysis → |
| DRMAW | Dermata Therapeutics, Inc. | STRONG SELL | 90% | View Analysis → |
| DMAC | DiaMedica Therapeutics Inc. | STRONG SELL | 90% | View Analysis → |
| DARE | Dare Bioscience, Inc. | STRONG SELL | 90% | View Analysis → |
| CYPH | CYPHERPUNK TECHNOLOGIES INC. | SELL | 90% | View Analysis → |
| CTXR | Citius Pharmaceuticals, Inc. | STRONG SELL | 90% | View Analysis → |
| CRVO | CervoMed Inc. | STRONG SELL | 90% | View Analysis → |
| CRMD | CorMedix Inc. | BUY | 90% | View Analysis → |
| CMPS | COMPASS Pathways plc | STRONG SELL | 90% | View Analysis → |
| CDTTW | CDT Equity Inc. | STRONG SELL | 90% | View Analysis → |
| CDIX | Cardiff Lexington Corp | STRONG SELL | 90% | View Analysis → |
| OCEA | Ocean Biomedical, Inc. | STRONG SELL | 89% | View Analysis → |
| NKTR | NEKTAR THERAPEUTICS | STRONG SELL | 89% | View Analysis → |
| JUNS | JUPITER NEUROSCIENCES, INC. | STRONG SELL | 89% | View Analysis → |
| IMUX | IMMUNIC, INC. | STRONG SELL | 89% | View Analysis → |
| CNTB | Connect Biopharma Holdings Ltd | SELL | 89% | View Analysis → |
| CLRB | Cellectar Biosciences, Inc. | STRONG SELL | 89% | View Analysis → |
| EOLS | Evolus, Inc. | SELL | 88% | View Analysis → |
| BHC | Bausch Health Companies Inc. | SELL | 88% | View Analysis → |
| ZNTL | Zentalis Pharmaceuticals, Inc. | STRONG SELL | 88% | View Analysis → |
| ZBIO | Zenas BioPharma, Inc. | STRONG SELL | 88% | View Analysis → |
| VTGN | Vistagen Therapeutics, Inc. | STRONG SELL | 88% | View Analysis → |
| TXMD | TherapeuticsMD, Inc. | STRONG SELL | 88% | View Analysis → |
| TRAW | Traws Pharma, Inc. | STRONG SELL | 88% | View Analysis → |
| TENX | TENAX THERAPEUTICS, INC. | STRONG SELL | 88% | View Analysis → |
| SPRY | ARS Pharmaceuticals, Inc. | STRONG SELL | 88% | View Analysis → |
| SLS | SELLAS Life Sciences Group, Inc. | SELL | 88% | View Analysis → |
| SCNX | Scienture Holdings, Inc. | STRONG SELL | 88% | View Analysis → |
| RVRC | Revium Rx. | STRONG SELL | 88% | View Analysis → |
| PULM | Pulmatrix, Inc. | STRONG SELL | 88% | View Analysis → |
| PTIXW | Protagenic Therapeutics, Inc.new | STRONG SELL | 88% | View Analysis → |
| PRTA | PROTHENA CORP PUBLIC LTD CO | STRONG SELL | 88% | View Analysis → |
| PRAX | Praxis Precision Medicines, Inc. | STRONG SELL | 88% | View Analysis → |
| PMVP | PMV Pharmaceuticals, Inc. | STRONG SELL | 88% | View Analysis → |
| PETS | PETMED EXPRESS INC | STRONG SELL | 88% | View Analysis → |
| LNAI | Lunai Bioworks Inc. | STRONG SELL | 88% | View Analysis → |
| KALA | KALA BIO, Inc. | STRONG SELL | 88% | View Analysis → |
| GNLX | GENELUX Corp | STRONG SELL | 88% | View Analysis → |
| NRXPW | NRX Pharmaceuticals, Inc. | STRONG SELL | 88% | View Analysis → |
| MIST | Milestone Pharmaceuticals Inc. | SELL | 88% | View Analysis → |
| MIRA | MIRA PHARMACEUTICALS, INC. | SELL | 88% | View Analysis → |
| MGNX | MACROGENICS INC | SELL | 88% | View Analysis → |
| MBIO | MUSTANG BIO, INC. | SELL | 88% | View Analysis → |
| IXHL | Incannex Healthcare Inc. | SELL | 88% | View Analysis → |
| IVEVF | Inventiva S.A. | SELL | 88% | View Analysis → |
| IRD | Opus Genetics, Inc. | SELL | 88% | View Analysis → |
| INVA | Innoviva, Inc. | BUY | 88% | View Analysis → |
| INSM | INSMED Inc | SELL | 88% | View Analysis → |
| GANX | Gain Therapeutics, Inc. | SELL | 88% | View Analysis → |
| FBRX | Forte Biosciences, Inc. | SELL | 88% | View Analysis → |
| DERM | Journey Medical Corp | SELL | 88% | View Analysis → |
| DCOY | Decoy Therapeutics Inc. | SELL | 88% | View Analysis → |
| CRVS | Corvus Pharmaceuticals, Inc. | SELL | 88% | View Analysis → |
| CARM | Carisma Therapeutics Inc. | SELL | 88% | View Analysis → |
| RARE | Ultragenyx Pharmaceutical Inc. | SELL | 87% | View Analysis → |
| CYTK | CYTOKINETICS INC | SELL | 87% | View Analysis → |
| AIRS | Airsculpt Technologies, Inc. | SELL | 87% | View Analysis → |
| ZVRA | ZEVRA THERAPEUTICS, INC. | SELL | 87% | View Analysis → |
| TPST | Tempest Therapeutics, Inc. | STRONG SELL | 87% | View Analysis → |
| SGMT | Sagimet Biosciences Inc. | STRONG SELL | 87% | View Analysis → |
| PCSA | Processa Pharmaceuticals, Inc. | STRONG SELL | 87% | View Analysis → |
| OMER | OMEROS CORP | STRONG SELL | 87% | View Analysis → |
| MTNB | Matinas BioPharma Holdings, Inc. | STRONG SELL | 87% | View Analysis → |
| ISCO | International Stem Cell CORP | SELL | 87% | View Analysis → |
| INM | InMed Pharmaceuticals Inc. | SELL | 87% | View Analysis → |
| ERAS | Erasca, Inc. | SELL | 87% | View Analysis → |
| CURX | Curanex Pharmaceuticals Inc | SELL | 87% | View Analysis → |
| CTMX | CytomX Therapeutics, Inc. | STRONG SELL | 87% | View Analysis → |
| CRBP | Corbus Pharmaceuticals Holdings, Inc. | SELL | 87% | View Analysis → |
| COGT | Cogent Biosciences, Inc. | SELL | 86% | View Analysis → |
| LLY | ELI LILLY & Co | BUY | 86% | View Analysis → |
| IMNN | Imunon, Inc. | STRONG SELL | 86% | View Analysis → |
| HSTC | HST Global, Inc. | STRONG SELL | 86% | View Analysis → |
| GOVX | GeoVax Labs, Inc. | STRONG SELL | 86% | View Analysis → |
| RMHI | Retrieve Medical Holdings, Inc. | STRONG SELL | 86% | View Analysis → |
| IRON | Disc Medicine, Inc. | SELL | 86% | View Analysis → |
| ELDN | Eledon Pharmaceuticals, Inc. | SELL | 86% | View Analysis → |
| DSGN | Design Therapeutics, Inc. | SELL | 86% | View Analysis → |
| CRNX | Crinetics Pharmaceuticals, Inc. | SELL | 86% | View Analysis → |
| CPRX | CATALYST PHARMACEUTICALS, INC. | BUY | 86% | View Analysis → |
| CNTN | Canton Strategic Holdings, Inc. | SELL | 86% | View Analysis → |
| CNTA | Centessa Pharmaceuticals plc | SELL | 86% | View Analysis → |
| PTGX | Protagonist Therapeutics, Inc | SELL | 85% | View Analysis → |
| ZOMDF | Zomedica Corp. | STRONG SELL | 85% | View Analysis → |
| XBIT | XBiotech Inc. | STRONG SELL | 85% | View Analysis → |
| XBIO | Xenetic Biosciences, Inc. | STRONG SELL | 85% | View Analysis → |
| VTVT | vTv Therapeutics Inc. | SELL | 85% | View Analysis → |
| VERU | VERU INC. | SELL | 85% | View Analysis → |
| TOVX | Theriva Biologics, Inc. | STRONG SELL | 85% | View Analysis → |
| TOIIW | Oncology Institute, Inc. | STRONG SELL | 85% | View Analysis → |
| SXTPW | 60 DEGREES PHARMACEUTICALS, INC. | STRONG SELL | 85% | View Analysis → |
| SNNC | Sibannac, Inc. | STRONG SELL | 85% | View Analysis → |
| SMMT | Summit Therapeutics Inc. | STRONG SELL | 85% | View Analysis → |
| SER | Serina Therapeutics, Inc. | STRONG SELL | 85% | View Analysis → |
| RZLT | Rezolute, Inc. | STRONG SELL | 85% | View Analysis → |
| RCKTW | ROCKET PHARMACEUTICALS, INC. | STRONG SELL | 85% | View Analysis → |
| QNRX | Quoin Pharmaceuticals, Ltd. | STRONG SELL | 85% | View Analysis → |
| PYXS | Pyxis Oncology, Inc. | STRONG SELL | 85% | View Analysis → |
| PDSB | PDS Biotechnology Corp | STRONG SELL | 85% | View Analysis → |
| OWPC | One World Products, Inc. | STRONG SELL | 85% | View Analysis → |
| ONCY | ONCOLYTICS BIOTECH INC | STRONG SELL | 85% | View Analysis → |
| LIPO | LIPELLA PHARMACEUTICALS INC. | STRONG SELL | 85% | View Analysis → |
| HWH | HWH International Inc. | STRONG SELL | 85% | View Analysis → |
| MDNAF | Medicenna Therapeutics Corp. | SELL | 85% | View Analysis → |
| MDGL | MADRIGAL PHARMACEUTICALS, INC. | SELL | 85% | View Analysis → |
| MCRB | Seres Therapeutics, Inc. | STRONG SELL | 85% | View Analysis → |
| ENLV | Enlivex Ltd. | SELL | 85% | View Analysis → |
| DNTH | Dianthus Therapeutics, Inc. /DE/ | SELL | 85% | View Analysis → |
| LTRN | Lantern Pharma Inc. | STRONG SELL | 84% | View Analysis → |
| LITS | Lite Strategy, Inc. | SELL | 84% | View Analysis → |
| MBX | MBX Biosciences, Inc. | SELL | 84% | View Analysis → |
| LXRX | LEXICON PHARMACEUTICALS, INC. | SELL | 84% | View Analysis → |
| GERN | GERON CORP | SELL | 84% | View Analysis → |
| ELTP | ELITE PHARMACEUTICALS INC /NV/ | BUY | 84% | View Analysis → |
| EDSA | Edesa Biotech, Inc. | SELL | 84% | View Analysis → |
| DYN | Dyne Therapeutics, Inc. | SELL | 84% | View Analysis → |
| DRUG | BRIGHT MINDS BIOSCIENCES INC. | SELL | 84% | View Analysis → |
| CVSI | CV Sciences, Inc. | STRONG SELL | 84% | View Analysis → |
| CUE | Cue Biopharma, Inc. | SELL | 84% | View Analysis → |
| CTNM | Contineum Therapeutics, Inc. | SELL | 84% | View Analysis → |
| CNTX | Context Therapeutics Inc. | SELL | 84% | View Analysis → |
| CBIO | CRESCENT BIOPHARMA, INC. | SELL | 84% | View Analysis → |
| CATX | Perspective Therapeutics, Inc. | SELL | 84% | View Analysis → |
| OGEN | ORAGENICS INC | STRONG SELL | 83% | View Analysis → |
| LIXT | LIXTE BIOTECHNOLOGY HOLDINGS, INC. | SELL | 83% | View Analysis → |
| HIND | Vyome Holdings, Inc | SELL | 83% | View Analysis → |
| GTBP | GT Biopharma, Inc. | STRONG SELL | 83% | View Analysis → |
| MRKR | Marker Therapeutics, Inc. | SELL | 83% | View Analysis → |
| EWTX | Edgewise Therapeutics, Inc. | SELL | 83% | View Analysis → |
| ALKS | Alkermes plc. | SELL | 82% | View Analysis → |
| INDV | Indivior Pharmaceuticals, Inc. | SELL | 82% | View Analysis → |
| ARDX | ARDELYX, INC. | SELL | 82% | View Analysis → |
| UTHR | UNITED THERAPEUTICS Corp | STRONG BUY | 82% | View Analysis → |
| TDOC | Teladoc Health, Inc. | SELL | 82% | View Analysis → |
| WVE | Wave Life Sciences Ltd. | STRONG SELL | 82% | View Analysis → |
| SCYX | SCYNEXIS INC | SELL | 82% | View Analysis → |
| MTVA | MetaVia Inc. | SELL | 82% | View Analysis → |
| LSTA | LISATA THERAPEUTICS, INC. | STRONG SELL | 82% | View Analysis → |
| HYPD | HYPERION DEFI, INC. | STRONG SELL | 82% | View Analysis → |
| HOWL | Werewolf Therapeutics, Inc. | STRONG SELL | 82% | View Analysis → |
| GNPX | Genprex, Inc. | STRONG SELL | 82% | View Analysis → |
| RNAZ | Transcode Therapeutics, Inc. | STRONG SELL | 82% | View Analysis → |
| NNVC | NANOVIRICIDES, INC. | SELL | 82% | View Analysis → |
| MRVI | MARAVAI LIFESCIENCES HOLDINGS, INC. | SELL | 82% | View Analysis → |
| MNOV | MEDICINOVA INC | SELL | 82% | View Analysis → |
| JANX | Janux Therapeutics, Inc. | SELL | 82% | View Analysis → |
| EPRX | EUPRAXIA PHARMACEUTICALS INC. | SELL | 82% | View Analysis → |
| ELVN | Enliven Therapeutics, Inc. | SELL | 82% | View Analysis → |
| CAPR | CAPRICOR THERAPEUTICS, INC. | SELL | 82% | View Analysis → |
| CAMP | Camp4 Therapeutics Corp | SELL | 82% | View Analysis → |
| VRTX | VERTEX PHARMACEUTICALS INC / MA | BUY | 81% | View Analysis → |
| ROIV | Roivant Sciences Ltd. | SELL | 81% | View Analysis → |
| EQ | Equillium, Inc. | SELL | 81% | View Analysis → |
| OKUR | OnKure Therapeutics, Inc. | SELL | 80% | View Analysis → |
| ADCT | ADC Therapeutics SA | SELL | 80% | View Analysis → |
| REGN | REGENERON PHARMACEUTICALS, INC. | BUY | 80% | View Analysis → |
| FULC | Fulcrum Therapeutics, Inc. | SELL | 80% | View Analysis → |
| VERA | Vera Therapeutics, Inc. | SELL | 80% | View Analysis → |
| TTRX | Turn Therapeutics Inc. | STRONG SELL | 80% | View Analysis → |
| LPCN | Lipocine Inc. | SELL | 80% | View Analysis → |
| IGC | IGC Pharma, Inc. | SELL | 80% | View Analysis → |
| IBIO | iBio, Inc. | STRONG SELL | 80% | View Analysis → |
| GRI | GRI Bio, Inc. | SELL | 80% | View Analysis → |
| MPLT | MapLight Therapeutics, Inc. | SELL | 80% | View Analysis → |
| FBIOP | Fortress Biotech, Inc. | SELL | 80% | View Analysis → |
| DAWN | Day One Biopharmaceuticals, Inc. | SELL | 80% | View Analysis → |
| COYA | Coya Therapeutics, Inc. | SELL | 80% | View Analysis → |
| COLL | COLLEGIUM PHARMACEUTICAL, INC | BUY | 80% | View Analysis → |
| CMMB | Chemomab Therapeutics Ltd. | SELL | 80% | View Analysis → |
| KYNB | KYNTRA BIO, INC. | SELL | 79% | View Analysis → |
| HRMY | Harmony Biosciences Holdings, Inc. | BUY | 79% | View Analysis → |
| GRDX | GridAI Technologies Corp. | SELL | 79% | View Analysis → |
| MLTX | MoonLake Immunotherapeutics | SELL | 79% | View Analysis → |
| SDGR | Schrodinger, Inc. | SELL | 78% | View Analysis → |
| CYCN | Cyclerion Therapeutics, Inc. | SELL | 78% | View Analysis → |
| PCRX | Pacira BioSciences, Inc. | SELL | 78% | View Analysis → |
| MRK | Merck & Co., Inc. | HOLD | 78% | View Analysis → |
| EBS | Emergent BioSolutions Inc. | SELL | 78% | View Analysis → |
| IONS | IONIS PHARMACEUTICALS INC | SELL | 78% | View Analysis → |
| AGIO | AGIOS PHARMACEUTICALS, INC. | SELL | 78% | View Analysis → |
| URGN | UroGen Pharma Ltd. | STRONG SELL | 78% | View Analysis → |
| TRDA | Entrada Therapeutics, Inc. | SELL | 78% | View Analysis → |
| TNGX | Tango Therapeutics, Inc. | SELL | 78% | View Analysis → |
| TERN | Terns Pharmaceuticals, Inc. | SELL | 78% | View Analysis → |
| STTK | Shattuck Labs, Inc. | SELL | 78% | View Analysis → |
| SBFMW | Sunshine Biopharma Inc. | SELL | 78% | View Analysis → |
| RAPP | Rapport Therapeutics, Inc. | STRONG SELL | 78% | View Analysis → |
| PVLA | PALVELLA THERAPEUTICS, INC. | HOLD | 78% | View Analysis → |
| PTPI | Petros Pharmaceuticals, Inc. | STRONG SELL | 78% | View Analysis → |
| PLYX | Polaryx Therapeutics, Inc. | SELL | 78% | View Analysis → |
| NXTC | NextCure, Inc. | SELL | 78% | View Analysis → |
| NAMSW | NewAmsterdam Pharma Co N.V. | SELL | 78% | View Analysis → |
| LFCR | LIFECORE BIOMEDICAL, INC. DE | SELL | 78% | View Analysis → |
| KPHMW | KIORA PHARMACEUTICALS INC | SELL | 78% | View Analysis → |
| JBIO | Jade Biosciences, Inc. | SELL | 78% | View Analysis → |
| RNAC | Cartesian Therapeutics, Inc. | SELL | 78% | View Analysis → |
| NUVL | Nuvalent, Inc. | SELL | 78% | View Analysis → |
| MREO | Mereo BioPharma Group plc | SELL | 78% | View Analysis → |
| MLYS | Mineralys Therapeutics, Inc. | SELL | 78% | View Analysis → |
| ENTA | ENANTA PHARMACEUTICALS INC | SELL | 78% | View Analysis → |
| ELAN | Elanco Animal Health Inc | SELL | 78% | View Analysis → |
| CLYM | Climb Bio, Inc. | SELL | 78% | View Analysis → |
| CYRX | Cryoport, Inc. | SELL | 77% | View Analysis → |
| RMTI | ROCKWELL MEDICAL, INC. | SELL | 77% | View Analysis → |
| ESPR | Esperion Therapeutics, Inc. | SELL | 77% | View Analysis → |
| BMRN | BIOMARIN PHARMACEUTICAL INC | BUY | 76% | View Analysis → |
| AXSM | Axsome Therapeutics, Inc. | SELL | 76% | View Analysis → |
| NERV | Minerva Neurosciences, Inc. | SELL | 76% | View Analysis → |
| KAPA | Kairos Pharma, LTD. | SELL | 76% | View Analysis → |
| IMNM | Immunome Inc. | SELL | 76% | View Analysis → |
| HRTX | HERON THERAPEUTICS, INC. /DE/ | SELL | 76% | View Analysis → |
| CELG-RI | BRISTOL MYERS SQUIBB CO | BUY | 76% | View Analysis → |
| CAH | CARDINAL HEALTH INC | SELL | 76% | View Analysis → |
| SRPT | Sarepta Therapeutics, Inc. | SELL | 75% | View Analysis → |
| CORT | CORCEPT THERAPEUTICS INC | SELL | 75% | View Analysis → |
| AMRN | AMARIN CORP PLCUK | SELL | 75% | View Analysis → |
| SIGA | SIGA TECHNOLOGIES INC | HOLD | 75% | View Analysis → |
| RPRX | Royalty Pharma plc | HOLD | 75% | View Analysis → |
| PCYN | PROCYON CORP | SELL | 75% | View Analysis → |
| LRMR | Larimar Therapeutics, Inc. | SELL | 75% | View Analysis → |
| HIMS | Hims & Hers Health, Inc. | BUY | 75% | View Analysis → |
| GRDN | Guardian Pharmacy Services, Inc. | BUY | 75% | View Analysis → |
| GLSI | Greenwich LifeSciences, Inc. | STRONG SELL | 75% | View Analysis → |
| CPIX | CUMBERLAND PHARMACEUTICALS INC | SELL | 75% | View Analysis → |
| OPK | OPKO HEALTH, INC. | SELL | 74% | View Analysis → |
| ABT | ABBOTT LABORATORIES | HOLD | 74% | View Analysis → |
| OVID | Ovid Therapeutics Inc. | SELL | 74% | View Analysis → |
| NGNE | Neurogene Inc. | SELL | 74% | View Analysis → |
| LGNZZ | LIGAND PHARMACEUTICALS INC | BUY | 74% | View Analysis → |
| KRRO | Korro Bio, Inc. | SELL | 74% | View Analysis → |
| HLF | HERBALIFE LTD. | SELL | 74% | View Analysis → |
| RNXT | RenovoRx, Inc. | SELL | 74% | View Analysis → |
| MNPR | Monopar Therapeutics | SELL | 74% | View Analysis → |
| COR | Cencora, Inc. | SELL | 74% | View Analysis → |
| STOK | Stoke Therapeutics, Inc. | BUY | 73% | View Analysis → |
| KROS | Keros Therapeutics, Inc. | BUY | 73% | View Analysis → |
| GPCR | Structure Therapeutics Inc. | SELL | 73% | View Analysis → |
| VRDN | Viridian Therapeutics, Inc.\DE | STRONG SELL | 72% | View Analysis → |
| RYTM | RHYTHM PHARMACEUTICALS, INC. | SELL | 72% | View Analysis → |
| ZYME | Zymeworks Inc. | SELL | 72% | View Analysis → |
| VREOF | Vireo Growth Inc. | SELL | 72% | View Analysis → |
| TYRA | Tyra Biosciences, Inc. | SELL | 72% | View Analysis → |
| TNXP | Tonix Pharmaceuticals Holding Corp. | SELL | 72% | View Analysis → |
| TELO | Telomir Pharmaceuticals, Inc. | SELL | 72% | View Analysis → |
| SYRE | Spyre Therapeutics, Inc. | SELL | 72% | View Analysis → |
| PRGO | PERRIGO Co plc | SELL | 72% | View Analysis → |
| PEPG | PepGen Inc. | SELL | 72% | View Analysis → |
| PBYI | PUMA BIOTECHNOLOGY, INC. | BUY | 72% | View Analysis → |
| ORKA | Oruka Therapeutics, Inc. | SELL | 72% | View Analysis → |
| LIFD | LFTD PARTNERS INC. | SELL | 72% | View Analysis → |
| LIANY | LianBio | SELL | 72% | View Analysis → |
| HOTH | Hoth Therapeutics, Inc. | SELL | 72% | View Analysis → |
| GRTX | Galera Therapeutics, Inc. | SELL | 72% | View Analysis → |
| REVBW | REVELATION BIOSCIENCES, INC. | SELL | 72% | View Analysis → |
| NRIX | Nurix Therapeutics, Inc. | SELL | 72% | View Analysis → |
| MIRM | Mirum Pharmaceuticals, Inc. | BUY | 72% | View Analysis → |
| OCUL | OCULAR THERAPEUTIX, INC | SELL | 71% | View Analysis → |
| RLYB | Rallybio Corp | SELL | 71% | View Analysis → |
| RLMD | RELMADA THERAPEUTICS, INC. | STRONG SELL | 71% | View Analysis → |
| BIOA | BioAge Labs, Inc. | HOLD | 70% | View Analysis → |
| TGTX | TG THERAPEUTICS, INC. | SELL | 70% | View Analysis → |
| VSTM | Verastem, Inc. | SELL | 70% | View Analysis → |
| VRCA | Verrica Pharmaceuticals Inc. | SELL | 70% | View Analysis → |
| SBCWW | SBC Medical Group Holdings Inc | HOLD | 70% | View Analysis → |
| PTCT | PTC THERAPEUTICS, INC. | HOLD | 70% | View Analysis → |
| PRLD | Prelude Therapeutics Inc | SELL | 70% | View Analysis → |
| NKTX | Nkarta, Inc. | SELL | 70% | View Analysis → |
| NATR | NATURES SUNSHINE PRODUCTS INC | HOLD | 70% | View Analysis → |
| LEXX | Lexaria Bioscience Corp. | SELL | 70% | View Analysis → |
| LBRX | LB PHARMACEUTICALS INC | SELL | 70% | View Analysis → |
| KZR | Kezar Life Sciences, Inc. | SELL | 70% | View Analysis → |
| RFL | Rafael Holdings, Inc. | SELL | 70% | View Analysis → |
| IRWD | IRONWOOD PHARMACEUTICALS INC | HOLD | 70% | View Analysis → |
| OLMA | Olema Pharmaceuticals, Inc. | SELL | 69% | View Analysis → |
| KURA | Kura Oncology, Inc. | SELL | 69% | View Analysis → |
| HROW | HARROW, INC. | BUY | 69% | View Analysis → |
| GRCE | Grace Therapeutics, Inc. | HOLD | 69% | View Analysis → |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | HOLD | 68% | View Analysis → |
| JAZZ | Jazz Pharmaceuticals plc | SELL | 68% | View Analysis → |
| TVTX | Travere Therapeutics, Inc. | HOLD | 68% | View Analysis → |
| NUVB | Nuvation Bio Inc. | HOLD | 68% | View Analysis → |
| XOMAP | XOMA Royalty Corp | HOLD | 68% | View Analysis → |
| XNCR | Xencor Inc | SELL | 68% | View Analysis → |
| XERS | Xeris Biopharma Holdings, Inc. | SELL | 68% | View Analysis → |
| TBPH | Theravance Biopharma, Inc. | BUY | 68% | View Analysis → |
| SPRO | Spero Therapeutics, Inc. | BUY | 68% | View Analysis → |
| SNSE | Sensei Biotherapeutics, Inc. | SELL | 68% | View Analysis → |
| SLNO | SOLENO THERAPEUTICS INC | HOLD | 68% | View Analysis → |
| SION | Sionna Therapeutics, Inc. | SELL | 68% | View Analysis → |
| QTTB | Q32 Bio Inc. | HOLD | 68% | View Analysis → |
| PLRX | PLIANT THERAPEUTICS, INC. | STRONG SELL | 68% | View Analysis → |
| INBP | INTEGRATED BIOPHARMA INC | SELL | 68% | View Analysis → |
| IMRX | Immuneering Corp | SELL | 68% | View Analysis → |
| IMMX | Immix Biopharma, Inc. | SELL | 68% | View Analysis → |
| FOLD | AMICUS THERAPEUTICS, INC. | BUY | 68% | View Analysis → |
| NVCT | Nuvectis Pharma, Inc. | SELL | 67% | View Analysis → |
| SEPN | Septerna, Inc. | BUY | 67% | View Analysis → |
| ORMP | ORAMED PHARMACEUTICALS INC. | SELL | 67% | View Analysis → |
| KTTAW | Pasithea Therapeutics Corp. | SELL | 67% | View Analysis → |
| RIGL | RIGEL PHARMACEUTICALS INC | HOLD | 67% | View Analysis → |
| ETON | Eton Pharmaceuticals, Inc. | BUY | 67% | View Analysis → |
| ORIC | Oric Pharmaceuticals, Inc. | SELL | 66% | View Analysis → |
| KNSA | Kiniksa Pharmaceuticals International, plc | BUY | 66% | View Analysis → |
| NEUP | Neuphoria Therapeutics Inc. | SELL | 66% | View Analysis → |
| LQDA | Liquidia Corp | SELL | 66% | View Analysis → |
| RCUS | Arcus Biosciences, Inc. | SELL | 65% | View Analysis → |
| PHAT | Phathom Pharmaceuticals, Inc. | SELL | 65% | View Analysis → |
| XLO | Xilio Therapeutics, Inc. | HOLD | 65% | View Analysis → |
| UPB | Upstream Bio, Inc. | SELL | 65% | View Analysis → |
| SPRB | SPRUCE BIOSCIENCES, INC. | SELL | 65% | View Analysis → |
| PHIO | Phio Pharmaceuticals Corp. | SELL | 65% | View Analysis → |
| PBH | Prestige Consumer Healthcare Inc. | BUY | 65% | View Analysis → |
| PAHC | PHIBRO ANIMAL HEALTH CORP | HOLD | 65% | View Analysis → |
| LFVN | Lifevantage Corp | HOLD | 64% | View Analysis → |
| ORGO | Organogenesis Holdings Inc. | HOLD | 64% | View Analysis → |
| NUS | NU SKIN ENTERPRISES, INC. | SELL | 64% | View Analysis → |
| LFMDP | LifeMD, Inc. | BUY | 63% | View Analysis → |
| GYRE | GYRE THERAPEUTICS, INC. | HOLD | 63% | View Analysis → |
| MNKD | MANNKIND CORP | HOLD | 63% | View Analysis → |
| PFE | PFIZER INC | HOLD | 60% | View Analysis → |
| MSLE | Satellos Bioscience Inc. | SELL | 58% | View Analysis → |
| HOOK | HOOKIPA Pharma Inc. | SELL | 56% | View Analysis → |
| IDYA | IDEAYA Biosciences, Inc. | HOLD | 54% | View Analysis → |
| KALV | KalVista Pharmaceuticals, Inc. | HOLD | 54% | View Analysis → |
| ETST | Earth Science Tech, Inc. | HOLD | 52% | View Analysis → |
| CANF | Can-Fite BioPharma Ltd. | SELL | 52% | View Analysis → |
| TRVI | Trevi Therapeutics, Inc. | SELL | 50% | View Analysis → |
| SNDX | Syndax Pharmaceuticals Inc | HOLD | 48% | View Analysis → |
| RANI | Rani Therapeutics Holdings, Inc. | SELL | 48% | View Analysis → |
| CCM | Concord Medical Services Holdings Ltd | SELL | 47% | View Analysis → |
| GENB | Generate Biomedicines, Inc. | SELL | 46% | View Analysis → |
| VKTX | Viking Therapeutics, Inc. | SELL | 45% | View Analysis → |
| TEVJF | TEVA PHARMACEUTICAL INDUSTRIES LTD | HOLD | 45% | View Analysis → |
| GDTC | CytoMed Therapeutics Ltd | SELL | 44% | View Analysis → |
| EVOTF | Evotec SE | SELL | 44% | View Analysis → |
| GHRS | GH Research PLC | HOLD | 40% | View Analysis → |
| ZLAB | Zai Lab Ltd | HOLD | 38% | View Analysis → |
| SYBX | SYNLOGIC, INC. | STRONG SELL | 35% | View Analysis → |
| RLFTF | Relief Therapeutics Holding SA | SELL | 32% | View Analysis → |
| RDGT | Ridgetech Inc. | SELL | 22% | View Analysis → |
| RNA | Atrium Therapeutics, Inc. | SELL | 21% | View Analysis → |
| NRSNW | NeuroSense Therapeutics Ltd. | HOLD | 20% | View Analysis → |
| NSRX | Nasus Pharma Ltd | HOLD | 18% | View Analysis → |
| NONOF | NOVO NORDISK A S | HOLD | 18% | View Analysis → |
| RDHL | RedHill Biopharma Ltd. | HOLD | 16% | View Analysis → |
| RDY | DR REDDYS LABORATORIES LTD | HOLD | 15% | View Analysis → |
| RDPTF | Radiopharm Theranostics Ltd | HOLD | 14% | View Analysis → |
Frequently Asked Questions: Pharmaceutical Stocks
What are the best pharmaceutical stocks to buy in 2026?
Based on our dual AI fundamental analysis (Claude and ChatGPT), 28 pharmaceutical stocks have Buy or Strong Buy ratings in 2026. These are ranked by confidence score based on SEC 10-K and 10-Q filing analysis.
Which pharmaceutical stocks have Strong Buy ratings?
Currently, 1 pharmaceutical stocks have a Strong Buy rating from our AI analysis. Strong Buy indicates both Claude and ChatGPT agree on exceptional fundamentals with high confidence scores above 80%.
How does AI analyze pharmaceutical stocks?
Our dual AI system analyzes SEC EDGAR filings including revenue growth, profit margins, ROE, ROA, debt levels, and cash flow. Both Claude (Anthropic) and ChatGPT (OpenAI) independently evaluate each stock, then we combine their ratings for higher accuracy.
What is the AI confidence score?
AI confidence scores range from 0-100% and indicate how strongly the AI models agree on their rating. Higher confidence means clearer signals from SEC filing data. Pharmaceutical stocks with 80%+ confidence have the most reliable ratings.
Should I invest in pharmaceutical stocks in 2026?
Our AI analysis shows 28 Buy ratings vs 383 Sell ratings in the pharmaceutical sector. Individual stock fundamentals vary significantly - review each stock's detailed analysis. This is not investment advice.
How often are pharmaceutical stock ratings updated?
AI ratings are updated whenever companies file new SEC reports (10-K annually, 10-Q quarterly). Most pharmaceutical stocks are re-analyzed within 24-48 hours of new filings being published on SEC EDGAR.
What data sources are used for pharmaceutical stock analysis?
All analysis is based on official SEC EDGAR filings including Form 10-K (annual reports), Form 10-Q (quarterly reports), and other regulatory disclosures. We do not use price data or market sentiment - only fundamental financial data.
Compare Top Pharmaceutical Stocks
Part of: 💊 Healthcare Sector